Skip to main content
. 2021 May 18;39(4):1381–1390. doi: 10.1007/s12640-021-00375-5

Fig. 1.

Fig. 1

Schematic diagram depicting current pharmacotherapies for PD which result in symptomatic relief of symptoms due increase in the striatal DA (left panel). Potential novel intervention that may target the neurodegenerative aspect of the disease and may also help with nonmotor symptoms (right panel)